Junction, a healthcare infrastructure company, has announced an $18 million Series A funding round led by Creandum, with participation from Y Combinator, Point Nine, Amino Collective, and Inflect Health. The investment aims to accelerate the modernization of healthcare's foundational systems and enable the future of personalized care.
The funding comes at a critical time for healthcare, which is undergoing a significant paradigm shift as care increasingly moves from traditional hospital settings to patients' homes. However, the current healthcare infrastructure struggles to support this transition effectively.
Today's healthcare systems rely heavily on manual lab integrations, faxes, and siloed devices, creating several challenges for the industry. These outdated approaches lead to delayed care through lengthy integration processes, missed diagnoses due to manual follow-ups and inconvenient patient access, operational strain as care teams waste valuable time on administrative tasks, and high costs coupled with low adherence rates.
Junction's modern infrastructure addresses these issues by making patient data accessible, actionable, and automated across lab testing and device integrations. The platform offers several key features to streamline healthcare operations and improve patient care.
The company enables seamless lab ordering across all 50 states, with results from major laboratories like LabCorp and Quest, via both in-person or at-home testing. Their automated workflows significantly reduce manual work for clinical teams, ensuring a smooth data flow throughout the care process. Junction also improves patient adherence with real-time status updates and reminders.
Additionally, the platform integrates with over 500 wearables and medical devices, providing healthcare providers with a comprehensive longitudinal view of patient health.
Junction has experienced remarkable growth, expanding its integrations to serve over 140 healthcare organizations, including digital health leaders like Found, Parsley Health, and Evidation. The company currently supports over 500,000 lab tests annually and manages more than 2 million connected devices.
This significant investment will enable Junction to scale its platform, expand its team, and grow its API network, empowering healthcare organizations to deliver smarter and more connected patient care. Alongside the funding announcement, the company unveiled its new brand name, Junction, reflecting its role in bridging gaps between fragmented healthcare systems.
Click here for the original news story.